Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,194 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens

NCT03092739

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • Vseobecna fakultni nemocnice v Praze; I. klinika tuberkulozy a respiracnich nemoci Prague, Czechia
  • Universitätsklinikum Göttingen, Institut für Pathologie Göttingen, Germany
  • Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc Warsaw, Poland
  • Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Anatomía Patológica A Coruña, LA Coruña, Spain
View Trial Details
Completed

Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa

NCT02304406

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • National Cancer Institute Cairo, Egypt
  • National Cancer Institute Cairo / Misr Al Qadimah, Egypt
  • American University in Beirut Beirut, Lebanon
  • American University of Beirut Beirut, Lebanon
View Trial Details
Completed

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

NCT00874211

Conditions
Blood Protein Disorders, Breast Cancer, Breast Diseases, +45 more
Locations
  • Regional Medical Center Anniston, Alabama, United States
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks, Alaska, United States
View all 453 locations
View Trial Details
Completed

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

NCT00428220

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +62 more
Locations
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
  • Investigational Drug Service Atlanta, Georgia, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
View all 113 locations
View Trial Details
Completed

Comparison of IV Topotecan/Docetaxel to Docetaxel Alone in Second-Line Stage IIIB/IV Non-Small Cell Lung Cancer

NCT00065182

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • GSK Investigational Site Huntsville, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
View all 85 locations
View Trial Details
Completed

Oncoxin® and Quality of Life in Cancer Patients

NCT03550482

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
Locations
  • Kazakh Research Institute of Oncology and Radiology Almaty, Kazakhstan
  • State Municipal Enterprise on the Right of Economic Management "Almaty Oncology Center" of Almaty Healthcare Administration Almaty, Kazakhstan
  • State-funded Institution of Khanty-Mansiysk Regional Clinical Hospital Ugra, Tyumen Oblast, Russia
  • Medical Center "EVIMED" LLC Chelyabinsk, Russia
View Trial Details

Related conditions